We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




First US Extracardiac Tricuspid Valve Replacement Successful

By HospiMedica International staff writers
Posted on 03 Sep 2014
Henry Ford Hospital (HFH; Detroit, MI, USA) is the first hospital in the United States to perform transcatheter tricuspid valve replacement outside of the human heart.

The unique transcatheter tricuspid valve replacement procedure (pioneered in Germany) was performed on a woman who was not a candidate for traditional open heart surgery, due to prior medical procedures. More...
In preparation for the surgery, researchers at the Henry Ford Innovation Institute used three dimensional (3D) modeling to create a working replica of the patient’s heart, which helped the surgical team properly plan the procedure, and predetermine an appropriately sized valve.

The woman’s tricuspid valve was replaced during a two-hour procedure on July 31, 2014. During the procedure, a catheter was threaded percutaneously through a vein in the patient’s groin to her upper abdomen. The first stage involved bracing the inferior vena cava (IVC) with an expandable metal stent. The catheter was then used to insert and expand a transcatheter aortic valve replacement (TAVR) at the junction of the right atrium and the IVC. Once deployed, the new valve stopped blood from leaking and pooling in the patient’s abdomen and lower extremities. The patient was released to her home five days postsurgery.

“There are a lot of people who have damage of the tricuspid valve, and the surgery is risky, so doctors just try to give them medical therapy,” said lead physician for the procedure William O’Neill, MD, medical director of the Henry Ford Center for Structural Heart Disease. “They get a lot of swelling and severe liver congestion. They’re in and out of the hospital, and it really causes a lot of morbidity, so there’s a huge, unmet clinical need. Individuals with this type of valve problem now have another option.”

Dr. O'Neill is an internationally recognized pioneer in interventional cardiology who also developed emergency angioplasty, now a common treatment for heart attacks. He also performed the first transvascular aortic valve replacement in the United States in 2005. He was assisted by Adam Greenbaum, MD, director of the Cardiac Catheterization Lab at HFH, and visiting cardiologist Brian O’Neill, MD, an assistant professor of medicine at the Temple Heart and Vascular Center (Philadelphia, PA, USA).

HFH, the flagship facility for the Henry Ford Health System, is an 802-bed tertiary care hospital, education and research complex in Detroit (MI, USA) which opened in 1915. It is one of the first hospitals in the United States to use a standard fee schedule and favor private or semi-private rooms over large wards. As founder Henry Ford viewed tobacco as being unhealthy, the hospital was one of the first hospitals in to institute a total ban on smoking. HFH annually trains more than 500 residents and 125 fellows in 46 accredited programs. More than 400 medical students train at the hospital each academic year.

Related Links:

Henry Ford Hospital



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical-Grade Display
HL2316SHTB
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: Lead study author Ramy Ghanim (left) and co-author Joy Jackson test an small implantable device alongside Assistant Professor Alex Abramson. In a new Science paper, they describe a networking system that connects therapeutic implants and wearable devices by using the body’s natural conductivity to send tiny signals. (Photo courtest of Georgia Tech)

Bioelectronic Network Enables Devices to Communicate Through Body Tissue and Coordinate Therapy

Wearable sensors and implanted therapeutic devices can be difficult to coordinate when signals must pass through the body. Conventional wireless signals do not travel well through tissue, while the antennas... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.